ELI LILLY & Co — Director's Dealing 2018

Sep 7, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-09-01

Reporting Person: White Anne E. (SVP & Pres-Lilly Oncology)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9603	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2018-12-02	Common Stock (7500.0)		Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.